JOINTRAL

ACTIVE PRINCIPLE INGREDIENT: glutathione sodium salt   INDICATONS: prophylaxis of neuropathies following chemoterapy with cisplatin or cisplatin analogues PHARMACEUTICAL FORM - DOSAGE: Powder and solution for injection 600mg/3ml IM - IV PACKAGE: 1 powder vial + 1 solv. ampoule  ...

ACTIVE PRINCIPLE INGREDIENT: Methylprednisolone sodium succinate INDICATIONS: Corticosteroid,  anti-inflammatory drug PHARMACEUTICAL FORM - DOSAGE:  20mg/2ml; 40mg/2ml; 120mg/2ml powder and solvent for solution for injection injection IM - IV;  500mg powder for solution for inj...

ACTIVE PRINCIPLE INGREDIENT: ibuprofen lysinate. INDICATIONS: NSAID. Chronic symptomatic treatment of rheumatoid arthritis and osteoarthritis.  PHARMACEUTICAL FORM - DOSAGE: injectable ampoules 3ml - 600mg    PACKAGE: 6 vials/box

ACTIVE PRINCIPLE INGREDIENT: Sucralfate gel.INDICATIONS: Gastric ulcer, duodenal ulcer, acute gastritis, symptomatic chronic gastritis, NSAID-related gastric pathologies, reflux esophagitis. PHARMACEUTICAL FORM - DOSAGE - PACKAGE: oral sachets   1g/5ml, 30 sachets/box  -   2...

ACTIVE PRINCIPLE INGREDIENT: Amikacin sulfate.INDICATIONS: Semi-synthetic aminoglycoside antibiotic with broad anti- gram positive/gram- negative spectrum.   PHARMACEUTICAL FORM - DOSAGE - PACKAGING: 1 vial 250mg/2ml IM-IV, 1 vial 500mg/2ml IM-IV, 1 vial 1g/4ml IM-IV.  1 vial 250mg/2ml IM...

ACTIVE PRINCIPLE INGREDIENT: Amikacin  sulphateINDICATIONS: Short-term treatment of serious infections caused by susceptible Gram-negative bacteria PHARMACEUTICAL FORM - DOSAGE: 5% gel PACKAGE: tube of 30g

ACTIVE PRINCIPLE INGREDIENT: Sucralfate humid gel  INDICATIONS: as adjuvant for the treatment of wounds, burns, bedsores, vascular ulcers, diabetic ulcers, radio dermatitis FORM - DOSAGE: 25% gel - 20% spray PACKAGE:  1 gel tube/box -  1 spray vial/box

ACTIVE PRINCIPLE INGREDIENT: clodronate disodium. INDICATIONS: Tumoral osteolysis, multiple myelosis, primary hyperparathyrodism, prevention and treatment of postmenopausal osteoporosis.  PACKAGE: 6/12 amps 100mg/3.3ml Im, 6 amps 300 mg/10ml infusion.

ACTIVE PRINCIPLE INGREDIENT: Atracurium besylate INDICATIONS:  ACURMIL is a highly-selective nondepolarizing neuromuscular blocker used in general anesthesia to facilitate endotracheal intubation and to obtain muscle relaxation in a wide range of surgical proc...

ACTIVE PRINCIPLE INGREDIENT: Synthetic calcitonin INDICATIONS:  Prevention of acute bone loss due to sudden immobilization such as in patients who have recently suffered osteoporotic bone fractures. Treatment of Paget’s disease, only in patients who do not respond t...